Results 141 to 150 of about 4,819 (199)

Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review. [PDF]

Cureus
Leiber KK, Parker RW.
europepmc   +1 more source

Pharmacokinetics and Safety of Oxycodone/Naloxone Prolonged-Release Tablets in Chinese Patients with Chronic Pain. [PDF]

Drug Des Devel Ther
He Y, Yang L, Mou Q, Cao X, Zhu X, Wang Y, Luo Z.   +6 more
europepmc   +1 more source

Physiologically based pharmacokinetic modeling of long-acting extended-release naltrexone in pregnant women with opioid use disorder. [PDF]

CPT Pharmacometrics Syst Pharmacol
Shenkoya B, Gopalakrishnan M, Eke AC.
europepmc   +1 more source

Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024. [PDF]

Nat Sci Sleep
Wei S, Song X, Chen R, Chen S, Lu B.
europepmc   +1 more source

Naltrexone Hydrochloride Loaded W/O Microemulsions: Preparation, Characterization and Exploring the Anti-leishmanial Activity

İstanbul Journal of Pharmacy
Emine Özyılmaz, Emrah Güler, Kaya Süer, Ahmet Özbilgin, İbrahim Çavuş, Tansel Çomoğlu   +5 more
openaire   +1 more source

Evaluation of the Antinociceptive Effect of Sesamin: Role of 5HT_1A Serotonergic Receptors. [PDF]

Pharmaceutics
Camacho-Cruz R, Alcalá-Hernández DF, Huerta-Cruz JC, Arrieta-Valencia J, Sánchez-Mendoza ME, Flores-Murrieta FJ, Navarrete A, Reyes-García JG, Rocha-González HI.   +8 more
europepmc   +1 more source

Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference. [PDF]

Neuropsychopharmacol Rep
Ide S, Iwase N, Arai K, Kojima M, Ushiyama S, Ikeda K.   +5 more
europepmc   +1 more source